CaPP3 Study opens to recruitment

posted on Monday, 13th October 2014

Not tagged.


The CaPP3 study opened to recruitment at the Institute of Genetic Medicine, Newcastle on Wednesday 1st October 2014. Professor Sir John Burn consented the first recruit.

The first batch of packed aspirin has been delivered to the pharmacy in Newcastle ready for dispensing.

The study will be recruiting through all the UK Regional Genetics Centres. Over the next few months these centres too will be opening to recruitment, once they have completed their local regulatory processes.

So after several long years of working our way through UK regulatory processes the CaPP3 study is finally open to recruitment.

Nick James was the first to be recruited to the trial in Newcastle.  Read his story at the link below:

Gosforth dad joins clinical trial that could cut risk of Lynch syndrome sufferers getting cancer

ChronicleLive, 7 October 2016


Share this!

Latest News


  • Review of the role of aspirin in preventing colorectal cancer

    posted on Tuesday, 24th October 2017

    Review of the role of aspirin in preventing colorectal cancer written by John Burn and his postdoctoral research assistant Harsh Sheth

  • Lynch Syndrome UK

    posted on Thursday, 5th March 2015

    Lynch Syndrome UK is a registered charity stemming from a long running support group on Facebook.  Our many members are passionate about our cause to educate and empower people living with this genetic condition and offering support to both them and their families when they need it most.